Gliatech (GLIA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (642)	2/15/1999 6:01:00 AM
From: puborectalis	Read Replies (1) of 2001

Be careful of investing in biotech firms with little or no high scientific visibility. The market floor is strewn with stocks that were driven up on hope and nothing else. For example....Humascan...Cell pathways....Cephalon....Viragen...etc. High profile journals include Spine, NEJM., American J of Gastroenterology not second rate journals as have been mentioned on this thread. It is,alright to be an investor in biotech companies but since 1992 they have underperformed this market in a big way unless you include majors like PFE,WLA,and LILLY.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next